{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:43:20Z","timestamp":1792478600067,"version":"4.5.0"},"reference-count":45,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15877","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:56:23Z","timestamp":1789991783000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["MAD2L1 overexpression promotes breast cancer progression and confers resistance to paclitaxel via proteasomal stabilization"],"prefix":"10.3892","volume":"32","author":[{"given":"Shih-Ho","family":"Wang","sequence":"first","affiliation":[{"name":"Division of General Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsi","family":"Yeh","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medical Research, E\u2011Da Cancer Hospital, I\u2011Shou University, Kaohsiung 82445, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yi","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eing-Mei","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ming","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Surgery, E\u2011Da Cancer Hospital, I\u2011Shou University, Kaohsiung 82445, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Wei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medical Research, E\u2011Da Cancer Hospital, I\u2011Shou University, Kaohsiung 82445, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hua","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Medical Research, E\u2011Da Cancer Hospital, I\u2011Shou University, Kaohsiung 82445, Taiwan, R.O.C."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"key20261020093253_b1-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s44197-025-00406-w","article-title":"Disease Burden of 30 cancer groups in Taiwan from 2000 to 2021","volume":"15","author":"Liu","year":"2025","journal-title":"J Epidemiol Glob Health"},{"key":"key20261020093253_b2-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"key20261020093253_b3-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer"},{"key":"key20261020093253_b4-ol-32-5-15877","first-page":"S3","article-title":"Taxol (paclitaxel): Mechanisms of action","volume":"5","author":"Horwitz","year":"1994","journal-title":"Ann Oncol"},{"key":"key20261020093253_b5-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1568009033481967","article-title":"Taxanes: Microtubule and centrosome targets, and cell cycle dependent mechanisms of action","volume":"3","author":"Abal","year":"2003","journal-title":"Curr Cancer Drug Targets"},{"key":"key20261020093253_b6-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/sj.onc.1204487","article-title":"Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1\/G2 arrest instead of mitotic arrest: Molecular determinants of paclitaxel-induced cytotoxicity","volume":"20","author":"Giannakakou","year":"2001","journal-title":"Oncogene"},{"key":"key20261020093253_b7-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/jnci\/88.18.1308","article-title":"Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel","volume":"88","author":"Milross","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"key20261020093253_b8-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1002\/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J","article-title":"Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together","volume":"88","author":"Wang","year":"2000","journal-title":"Cancer"},{"key":"key20261020093253_b9-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.17219\/acem\/127681","article-title":"Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K\/AKT signaling pathway","volume":"29","author":"Li","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"key20261020093253_b10-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2019.01.026","article-title":"Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer","volume":"448","author":"Fu","year":"2019","journal-title":"Cancer Lett"},{"key":"key20261020093253_b11-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/bcr2231","article-title":"Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells","volume":"11","author":"Nakayama","year":"2009","journal-title":"Breast Cancer Res"},{"key":"key20261020093253_b12-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1158\/1535-7163.MCT-04-0282","article-title":"Cyclin A-associated kinase activity is needed for paclitaxel sensitivity","volume":"4","author":"Takahashi","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"key20261020093253_b13-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.3390\/cancers7040897","article-title":"Paclitaxel through the ages of anticancer therapy: Exploring its role in chemoresistance and radiation therapy","volume":"7","author":"Barbuti","year":"2015","journal-title":"Cancers (Basel)"},{"key":"key20261020093253_b14-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13048-018-0399-7","article-title":"Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer","volume":"11","author":"Chong","year":"2018","journal-title":"J Ovarian Res"},{"key":"key20261020093253_b15-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ccr.2007.04.011","article-title":"Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs","volume":"11","author":"Swanton","year":"2007","journal-title":"Cancer Cell"},{"key":"key20261020093253_b16-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"1105184","DOI":"10.3389\/fgene.2023.1105184","article-title":"Maternal genetic polymorphisms in the major mitotic checkpoint genes MAD1L1 and MAD2L1 associated with the risk of survival in abnormal chromosomal fetuses","volume":"14","author":"Chan","year":"2023","journal-title":"Front Genet"},{"key":"key20261020093253_b17-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1600-0714.2009.00835.x","article-title":"Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas","volume":"39","author":"Ko","year":"2010","journal-title":"J Oral Pathol Med"},{"key":"key20261020093253_b18-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/cbin.11774","article-title":"Targeting of MAD2L1 by miR-515-5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells","volume":"46","author":"Ding","year":"2022","journal-title":"Cell Biol Int"},{"key":"key20261020093253_b19-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41417-022-00586-8","article-title":"MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer","volume":"30","author":"Li","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"key20261020093253_b20-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1044>3.0.CO;2-N","article-title":"Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells","volume":"29","author":"Percy","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"key20261020093253_b21-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"e0136246","DOI":"10.1371\/journal.pone.0136246","article-title":"Biological and clinical significance of MAD2L1 and BUB1, genes frequently appearing in expression signatures for breast cancer prognosis","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"key20261020093253_b22-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1007\/s00432-023-04613-5","article-title":"The positive feedback loop of MAD2L1\/TYK2\/STAT3 induces progression in B-cell acute lymphoblastic leukaemia","volume":"149","author":"Zhu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20261020093253_b23-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"e0243715","DOI":"10.1371\/journal.pone.0243715","article-title":"The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer","volume":"15","author":"Bates","year":"2020","journal-title":"PLoS One"},{"key":"key20261020093253_b24-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41467-021-21898-7","article-title":"Integrated cross-study datasets of genetic dependencies in cancer","volume":"12","author":"Pacini","year":"2021","journal-title":"Nat Commun"},{"key":"key20261020093253_b25-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: A cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"Dempster","year":"2021","journal-title":"Genome Biol"},{"key":"key20261020093253_b26-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20261020093253_b27-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"1524714","DOI":"10.3389\/fonc.2025.1524714","article-title":"Identification of MAD2L1 as a novel biomarker for hepatoblastoma through bioinformatics and machine learning approaches","volume":"15","author":"He","year":"2025","journal-title":"Front Oncol"},{"key":"key20261020093253_b28-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.3390\/ijms22115754","article-title":"The involvement of ubiquitination machinery in cell cycle regulation and cancer progression","volume":"22","author":"Zou","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20261020093253_b29-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-biochem-060410-105307","article-title":"Ubiquitin ligases and cell cycle control","volume":"82","author":"Teixeira","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"key20261020093253_b30-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"10027","DOI":"10.1038\/srep10027","article-title":"Breast cancer cell line MCF7 escapes from G1\/S arrest induced by proteasome inhibition through a GSK-3\u03b2 dependent mechanism","volume":"5","author":"Gavilan","year":"2015","journal-title":"Sci Rep"},{"key":"key20261020093253_b31-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1038\/s41388-023-02849-6","article-title":"MAD2 activates IGF1R\/PI3K\/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44\/LIMA1 complex","volume":"42","author":"Jiang","year":"2023","journal-title":"Oncogene"},{"key":"key20261020093253_b32-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"15552","DOI":"10.1074\/jbc.M111476200","article-title":"The cyclin-ubiquitin ligase activity of cyclosome\/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk","volume":"277","author":"Golan","year":"2002","journal-title":"J Biol Chem"},{"key":"key20261020093253_b33-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/ncb1983","article-title":"UBE2S elongates ubiquitin chains on APC\/C substrates to promote mitotic exit","volume":"11","author":"Garnett","year":"2009","journal-title":"Nat Cell Biol"},{"key":"key20261020093253_b34-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1073\/pnas.1522423113","article-title":"Control of APC\/C-dependent ubiquitin chain elongation by reversible phosphorylation","volume":"113","author":"Craney","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20261020093253_b35-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"key20261020093253_b36-ol-32-5-15877","first-page":"816","article-title":"Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death","volume":"56","author":"Jordan","year":"1996","journal-title":"Cancer Res"},{"key":"key20261020093253_b37-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1023\/A:1026422111457","article-title":"Cell cycle G2\/M arrest and activation of cyclin-dependent kinases associated with low-dose paclitaxel-induced sub-G1 apoptosis","volume":"2","author":"Shu","year":"1997","journal-title":"Apoptosis"},{"key":"key20261020093253_b38-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1200\/JCO.2007.11.9362","article-title":"Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment","volume":"26","author":"Albain","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20261020093253_b39-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1021\/jm990355x","article-title":"Paclitaxel derivatives for targeted therapy of cancer: toward the development of smart taxanes","volume":"42","author":"Safavy","year":"1999","journal-title":"J Med Chem"},{"key":"key20261020093253_b40-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00280-017-3398-2","article-title":"Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy","volume":"80","author":"Shi","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20261020093253_b41-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1021\/cr9000226","article-title":"ABC efflux pump-based resistance to chemotherapy drugs","volume":"109","author":"Eckford","year":"2009","journal-title":"Chem Rev"},{"key":"key20261020093253_b42-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbacli.2015.03.003","article-title":"The fate of chemoresistance in triple negative breast cancer (TNBC)","volume":"3","author":"O'Reilly","year":"2015","journal-title":"BBA Clin"},{"key":"key20261020093253_b43-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/bjc.2013.534","article-title":"Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells","volume":"109","author":"Liu","year":"2013","journal-title":"Br J Cancer"},{"key":"key20261020093253_b44-ol-32-5-15877","first-page":"27","article-title":"Paclitaxel-induced apoptosis may occur without a prior G2\/M-phase arrest","volume":"24","author":"Dziadyk","year":"2004","journal-title":"Anticancer Res"},{"key":"key20261020093253_b45-ol-32-5-15877","doi-asserted-by":"publisher","first-page":"e104419","DOI":"10.15252\/embj.2020104419","article-title":"Cyclin A triggers Mitosis either via the Greatwall kinase pathway or Cyclin B","volume":"39","author":"Hegarat","year":"2020","journal-title":"EMBO J"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:32:57Z","timestamp":1792477977000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,21]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15877","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}